CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents

about

CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents

Item

http://www.wikidata.org/entity/Q58746251

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents

@en

CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents

@nl

type

Item

label

CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents

@en

CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents

@nl

prefLabel

CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents

@en

CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents

@nl

P1476

CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents

@en

P2093

Chunyan Fang

http://www.w3.org/2001/XMLSchema#string

Hongan Zhang

http://www.w3.org/2001/XMLSchema#string

Hui Ma

http://www.w3.org/2001/XMLSchema#string

Huina Wu

http://www.w3.org/2001/XMLSchema#string

Jian Zhang

http://www.w3.org/2001/XMLSchema#string

Lihong Shi

http://www.w3.org/2001/XMLSchema#string

Meihua Qu

http://www.w3.org/2001/XMLSchema#string

Shujuan Liang

http://www.w3.org/2001/XMLSchema#string

Weiguo Song

http://www.w3.org/2001/XMLSchema#string

Xuejian Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatocellular carcinoma: Where are we?

Treatment of hepatocellular carcinoma: Steps forward but still a long way to go

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

Multidrug resistance in cancer: role of ATP-dependent transporters

Hepatocellular carcinoma

"Hepatocellular carcinoma: A life-threatening disease".

CD13 is a therapeutic target in human liver cancer stem cells

Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis.

Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges.

Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study.

P304

1042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.01042

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30258365

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

chemotherapy

P932

6144529

http://www.w3.org/2001/XMLSchema#string